166 related articles for article (PubMed ID: 9367065)
1. Antioxidant nutrients: associations with persistent human papillomavirus infection.
Giuliano AR; Papenfuss M; Nour M; Canfield LM; Schneider A; Hatch K
Cancer Epidemiol Biomarkers Prev; 1997 Nov; 6(11):917-23. PubMed ID: 9367065
[TBL] [Abstract][Full Text] [Related]
2. The association of plasma micronutrients with the risk of cervical dysplasia in Hawaii.
Goodman MT; Kiviat N; McDuffie K; Hankin JH; Hernandez B; Wilkens LR; Franke A; Kuypers J; Kolonel LN; Nakamura J; Ing G; Branch B; Bertram CC; Kamemoto L; Sharma S; Killeen J
Cancer Epidemiol Biomarkers Prev; 1998 Jun; 7(6):537-44. PubMed ID: 9641499
[TBL] [Abstract][Full Text] [Related]
3. Folate deficiency and cervical intraepithelial neoplasia.
Kwaśniewska A; Tukendorf A; Semczuk M
Eur J Gynaecol Oncol; 1997; 18(6):526-30. PubMed ID: 9443028
[TBL] [Abstract][Full Text] [Related]
4. Content of alpha-tocopherol in blood serum of human Papillomavirus-infected women with cervical dysplasias.
Kwaśniewska A; Tukendorf A; Semczuk M
Nutr Cancer; 1997; 28(3):248-51. PubMed ID: 9343832
[TBL] [Abstract][Full Text] [Related]
5. Serum micronutrients and cervical dysplasia in Southwestern American Indian women.
Yeo AS; Schiff MA; Montoya G; Masuk M; van Asselt-King L; Becker TM
Nutr Cancer; 2000; 38(2):141-50. PubMed ID: 11525590
[TBL] [Abstract][Full Text] [Related]
6. The clinical value of digene hybrid capture HPV DNA testing in a referral-based population with abnormal pap smears.
Recio FO; Sahai Srivastava BI; Wong C; Hempling RE; Eltabbakh GH; Piver MS
Eur J Gynaecol Oncol; 1998; 19(3):203-8. PubMed ID: 9641214
[TBL] [Abstract][Full Text] [Related]
7. Frequency of HPV infection and GSH levels in plasma of women with cervical dysplasia.
Kwaśniewska A; Tukendorf A; Semczuk M
Eur J Gynaecol Oncol; 1997; 18(3):196-9. PubMed ID: 9174835
[TBL] [Abstract][Full Text] [Related]
8. [Frequency of HPV infection and the level of ascorbic acid in serum of women with cervix dysplasia].
Kwaśniewska A; Tukendorf A; Semczuk M
Med Dosw Mikrobiol; 1996; 48(3-4):183-8. PubMed ID: 9182140
[TBL] [Abstract][Full Text] [Related]
9. Prediction of cervical intraepithelial neoplasia grade 2-3 using risk assessment and human papillomavirus testing in women with atypia on papanicolaou smears.
Shlay JC; Dunn T; Byers T; Barón AE; Douglas JM
Obstet Gynecol; 2000 Sep; 96(3):410-6. PubMed ID: 10960635
[TBL] [Abstract][Full Text] [Related]
10. Low grade cervical intraepithelial neoplasia associated with human papillomavirus infection. Long-term follow-up.
Matsuura Y; Kawagoe T; Toki N; Sugihara K; Kashimura M
Acta Cytol; 1998; 42(3):625-30. PubMed ID: 9622679
[TBL] [Abstract][Full Text] [Related]
11. High-risk cervical epithelial neoplasia grade 1 treated by loop electrosurgical excision: follow-up and value of HPV testing.
Alonso I; Torné A; Puig-Tintoré LM; Esteve R; Quinto L; Garcia S; Campo E; Pahisa J; Ordi J
Am J Obstet Gynecol; 2007 Oct; 197(4):359.e1-6. PubMed ID: 17714678
[TBL] [Abstract][Full Text] [Related]
12. Human papillomavirus detection by the hybrid capture II assay: a reliable test to select women with normal cervical smears at risk for developing cervical lesions.
Clavel C; Masure M; Levert M; Putaud I; Mangeonjean C; Lorenzato M; Nazeyrollas P; Gabriel R; Quereux C; Birembaut P
Diagn Mol Pathol; 2000 Sep; 9(3):145-50. PubMed ID: 10976721
[TBL] [Abstract][Full Text] [Related]
13. Long-term absolute risk of cervical intraepithelial neoplasia grade 3 or worse following human papillomavirus infection: role of persistence.
Kjær SK; Frederiksen K; Munk C; Iftner T
J Natl Cancer Inst; 2010 Oct; 102(19):1478-88. PubMed ID: 20841605
[TBL] [Abstract][Full Text] [Related]
14. [Level of retinol in blood serum of women infected with HPV and with dysplastic changes of the cervix].
Kwaśniewska A; Tukendorf A
Med Dosw Mikrobiol; 1996; 48(1-2):71-7. PubMed ID: 8926771
[TBL] [Abstract][Full Text] [Related]
15. Hawaii cohort study of serum micronutrient concentrations and clearance of incident oncogenic human papillomavirus infection of the cervix.
Goodman MT; Shvetsov YB; McDuffie K; Wilkens LR; Zhu X; Franke AA; Bertram CC; Kessel B; Bernice M; Sunoo C; Ning L; Easa D; Killeen J; Kamemoto L; Hernandez BY
Cancer Res; 2007 Jun; 67(12):5987-96. PubMed ID: 17553901
[TBL] [Abstract][Full Text] [Related]
16. Persistence and load of high-risk HPV are predictors for development of high-grade cervical lesions: a longitudinal French cohort study.
Dalstein V; Riethmuller D; Prétet JL; Le Bail Carval K; Sautière JL; Carbillet JP; Kantelip B; Schaal JP; Mougin C
Int J Cancer; 2003 Sep; 106(3):396-403. PubMed ID: 12845680
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of human papillomavirus testing in primary screening for cervical abnormalities: comparison of sensitivity, specificity, and frequency of referral.
Kulasingam SL; Hughes JP; Kiviat NB; Mao C; Weiss NS; Kuypers JM; Koutsky LA
JAMA; 2002 Oct; 288(14):1749-57. PubMed ID: 12365959
[TBL] [Abstract][Full Text] [Related]
18. Triage of atypical squamous cells of undetermined significance with hybrid capture II: colposcopy and histologic human papillomavirus correlation.
Lonky NM; Felix JC; Naidu YM; Wolde-Tsadik G
Obstet Gynecol; 2003 Mar; 101(3):481-9. PubMed ID: 12636951
[TBL] [Abstract][Full Text] [Related]
19. Human papillomavirus test with cytology triage in organized screening for cervical cancer.
Veijalainen O; Kares S; Kujala P; Tirkkonen M; Vuento R; Kholová I; Luukkaala T; Osuala V; Mäenpää J
Acta Obstet Gynecol Scand; 2016 Nov; 95(11):1220-1227. PubMed ID: 27591407
[TBL] [Abstract][Full Text] [Related]
20. Comparison of self-collected vaginal, vulvar and urine samples with physician-collected cervical samples for human papillomavirus testing to detect high-grade squamous intraepithelial lesions.
Sellors JW; Lorincz AT; Mahony JB; Mielzynska I; Lytwyn A; Roth P; Howard M; Chong S; Daya D; Chapman W; Chernesky M
CMAJ; 2000 Sep; 163(5):513-8. PubMed ID: 11006761
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
